MDS Pharma Services (Correction)
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has recommended that MDS Pharma Services conduct an expanded review of bioequivalence studies conducted at the company's Montreal bioanalytical facility over the last five years